ATE45183T1 - Expressionsvektoren fuer das antigene tollwutprotein und ihre verwendung zur herstellung von impfstoffen. - Google Patents

Expressionsvektoren fuer das antigene tollwutprotein und ihre verwendung zur herstellung von impfstoffen.

Info

Publication number
ATE45183T1
ATE45183T1 AT83400974T AT83400974T ATE45183T1 AT E45183 T1 ATE45183 T1 AT E45183T1 AT 83400974 T AT83400974 T AT 83400974T AT 83400974 T AT83400974 T AT 83400974T AT E45183 T1 ATE45183 T1 AT E45183T1
Authority
AT
Austria
Prior art keywords
gga
vaccines
antigen
production
expression
Prior art date
Application number
AT83400974T
Other languages
English (en)
Inventor
Marie-Paule Kieny
Richard Lathe
Jean-Pierre Lecocq
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE45183T1 publication Critical patent/ATE45183T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT83400974T 1982-05-13 1983-05-13 Expressionsvektoren fuer das antigene tollwutprotein und ihre verwendung zur herstellung von impfstoffen. ATE45183T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8208401A FR2526661B1 (fr) 1982-05-13 1982-05-13 Nouveaux vecteurs d'expression de la proteine antigenique de la rage et leur application a la preparation de vaccins
EP83400974A EP0094887B1 (de) 1982-05-13 1983-05-13 Expressionsvektoren für das antigene Tollwutprotein und ihre Verwendung zur Herstellung von Impfstoffen

Publications (1)

Publication Number Publication Date
ATE45183T1 true ATE45183T1 (de) 1989-08-15

Family

ID=9274023

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83400974T ATE45183T1 (de) 1982-05-13 1983-05-13 Expressionsvektoren fuer das antigene tollwutprotein und ihre verwendung zur herstellung von impfstoffen.

Country Status (7)

Country Link
EP (1) EP0094887B1 (de)
JP (1) JPS59501293A (de)
AT (1) ATE45183T1 (de)
CA (1) CA1193563A (de)
DE (1) DE3380309D1 (de)
FR (1) FR2526661B1 (de)
WO (1) WO1983004052A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002918A1 (fr) * 1983-01-21 1984-08-02 Transgene Sa NOUVEAUX VECTEURS D'EXPRESSION ET LEUR APPLICATION A LA PREPARATION D'UNE PROTEINE AYANT L'ACTIVITE DE L'ANTITRYPSINE-alpha1 HUMAINE
FR2556365B1 (fr) * 1983-12-09 1987-07-31 Transgene Sa Vecteurs de clonage et d'expression de l'interferon-g, bacteries transformees et procede de preparation de l'interferon-g
DE3586333T2 (de) * 1984-03-27 1992-12-10 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
FR2569420B2 (fr) * 1984-08-27 1988-02-12 Transgene Sa Vecteur d'expression de l'hirudine, procede pour sa preparation par culture de cellules transformees et hirudine obtenue
EP0162738A1 (de) * 1984-04-09 1985-11-27 MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP Herstellung von Untereinheiten von Pseudorabiesvirus-Vakzinen
US5830477A (en) * 1984-04-25 1998-11-03 Transgene S.A. Vaccine against rabies and process for preparation thereof
FR2563434B1 (fr) * 1984-04-25 1986-07-25 Transgene Sa Vaccin contre la rage et procede pour sa preparation
FR2564106B1 (fr) * 1984-05-09 1988-04-22 Transgene Sa Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
US5169763A (en) * 1986-04-08 1992-12-08 Transgene S.A., Institut Pasteur Viral vector coding glycoprotein of HIV-1
ES2081801T3 (es) * 1987-10-30 1996-03-16 Bristol Myers Squibb Co Plasmidos de expresion.
EP2239330A1 (de) 2009-04-07 2010-10-13 Institut Pasteur Neuronenerzeugung, -erneuerung und -schutz

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2712615A1 (de) * 1977-03-18 1978-09-21 Max Planck Gesellschaft Verfahren zur herstellung von filamentoesen phagen als vektor fuer synthetische rekombinate
IE63126B1 (en) * 1980-06-06 1995-03-22 Biogen Inc Improved vectors and methods for making such vectors and for expressing cloned genes

Also Published As

Publication number Publication date
EP0094887A3 (en) 1984-02-01
EP0094887B1 (de) 1989-08-02
DE3380309D1 (en) 1989-09-07
FR2526661B1 (fr) 1986-02-21
CA1193563A (fr) 1985-09-17
EP0094887A2 (de) 1983-11-23
FR2526661A1 (fr) 1983-11-18
WO1983004052A1 (fr) 1983-11-24
JPS59501293A (ja) 1984-07-26

Similar Documents

Publication Publication Date Title
NO871785D0 (no) Fremgangsmaate for fremstilling av et proteinprodukt, samt vektorsystem for fremgangsmaatens utfoerelse.
DE3650751D1 (de) Antikörper gegen Saugetier-Interleukin-4 und Peptide verwendbar als Antigenen für deren Herstellung
IT8521472A0 (it) Procedimento per la preparazione di fluoroelastomeri vulcanizzabili e prodotti cosi' ottenuti.
GB8912330D0 (en) Live vaccines
ATE159297T1 (de) Expression von menschlichen serumalbumin in methylotrophischen hefen
DK421687D0 (da) Vektorvirus, der baerer en heterolog dna-sekvens
DE3584579D1 (de) Herstellung von polypeptiden mit human-gammainterferon-aktivitaet.
ATE256182T1 (de) Neuartiges p- selectin ligandenprotein
DE3678609D1 (de) Partikel mit immunogenen hbs-antigen-eigenschaften und mit einer mit dem hbs-antigen-epitopen nichtverwandten antigenischen stelle, vektoren und tierische zellen fuer die herstellung dieser kombinierten impfstoffartikel.
DE3380309D1 (en) Expression vectors for rabies antigenic protein, and their use in the preparation of vaccines
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
DK0425082T3 (da) Vacciner
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.
EP0571771A3 (en) Method of inactivation of viruses in proteinic preparations
DE68904131D1 (de) Schweinenierenzellkultur und ihre verwendung fuer die herstellung von vakzinen.
AU532186B2 (en) Herpes virus vaccine
DK145988A (da) Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
ATE159758T1 (de) Azelluläre impfstoffe
DE59404408D1 (de) Verfahren zur Herstellung von Isocyansäure aus Cyanursäure
IT8622272A0 (it) Metodo per l'identificazione immediata da colture di salmonella e preparazione del reattivo impiegato.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties